Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Benedikt Judmann"'
Autor:
Benedikt Judmann, Nils F. Baier, Henning Rudolf, Güllü Davarci, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Publikováno v:
European Journal of Medicinal Chemistry Reports, Vol 12, Iss , Pp 100223- (2024)
The neuropeptide Y receptor subtype 1 (NPY(Y1)R) exhibits high expression rates on human breast cancer and is therefore an important target structure for the sensitive and specific visualization and characterization of the disease by Positron Emissio
Externí odkaz:
https://doaj.org/article/4d3a1d0a7d4c46b8be7c6dc3cbfb18a1
Autor:
Marie Prochiner, Benedikt Judmann, Alina Ruder, Björn Wängler, Ralf Schirrmacher, Carmen Wängler
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1280 (2024)
Background: Affibody molecules represent a class of highly specific binders of particular interest for the development of highly affine target-specific radiopharmaceuticals. Their chemical synthesis is, however, intricate due to their considerable le
Externí odkaz:
https://doaj.org/article/99280944783a41a89c6e96d3c0c160c9
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 273 (2023)
The human epidermal growth factor receptor (EGFR) is closely related to several cancer-promoting processes and overexpressed on a variety of tumor types, rendering it an important target structure for the imaging and therapy of several malignancies.
Externí odkaz:
https://doaj.org/article/be96c977e54a4450a2f09f1313406618
Autor:
Ralph Hübner, Alexa Paretzki, Valeska von Kiedrowski, Marco Maspero, Xia Cheng, Güllü Davarci, Diana Braun, Helen Damerow, Benedikt Judmann, Vasileios Filippou, Clelia Dallanoce, Ralf Schirrmacher, Björn Wängler, Carmen Wängler
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 531 (2021)
Recently, anionic charges were found to negatively influence the in vitro gastrin-releasing peptide receptor (GRPR) binding parameters of dually radioisotope and fluorescent dye labeled GRPR-specific peptide dimers. From this, the question arose if t
Externí odkaz:
https://doaj.org/article/d0175a4440d946068bdfd9f22a3e203b
Autor:
Benedikt Judmann, Diana Braun, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Publikováno v:
Pharmaceuticals, Vol 13, Iss 8, p 173 (2020)
Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field
Externí odkaz:
https://doaj.org/article/2611f8967a024c50aa6358d448bc0dcc
Autor:
Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Publikováno v:
ACS Omega. 8:2793-2807
Autor:
Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Publikováno v:
ACS Omega. 7:27690-27702
The epidermal growth factor receptor (EGFR) is closely associated with tumor development and progression and thus an important target structure for imaging and therapy of various tumors. As a result of its important role in malignancies of various or
Autor:
Helen Damerow, Ralph Hübner, Benedikt Judmann, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Publikováno v:
Cancers, Vol 13, Iss 6349, p 6349 (2021)
Cancers; Volume 13; Issue 24; Pages: 6349
Cancers; Volume 13; Issue 24; Pages: 6349
In this work, five different chelating agents, namely DFO, CTH-36, DFO*, 3,4,3-(LI-1,2-HOPO) and DOTA-GA, were compared with regard to the relative kinetic inertness of their corresponding 89Zr complexes to evaluate their potential for in vivo applic
Autor:
Diana Braun, Vasileios Filippou, Güllü Davarci, Helen Damerow, Valeska von Kiedrowski, Alexa Paretzki, Benedikt Judmann, Björn Wängler, Ralf Schirrmacher, Ralph Hübner, Clelia Dallanoce, Xia Cheng, Marco Maspero, Carmen Wängler
Publikováno v:
Pharmaceuticals
Volume 14
Issue 6
Pharmaceuticals, Vol 14, Iss 531, p 531 (2021)
Volume 14
Issue 6
Pharmaceuticals, Vol 14, Iss 531, p 531 (2021)
Recently, anionic charges were found to negatively influence the in vitro gastrin-releasing peptide receptor (GRPR) binding parameters of dually radioisotope and fluorescent dye labeled GRPR-specific peptide dimers. From this, the question arose if t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8d6c9a12445a34d9ceaef790f21101
http://elib.uni-stuttgart.de/handle/11682/12878
http://elib.uni-stuttgart.de/handle/11682/12878
Autor:
Björn Wängler, Benedikt Judmann, Gert Fricker, Diana Braun, Carmen Wängler, Ralf Schirrmacher
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 13, Iss 173, p 173 (2020)
Pharmaceuticals, Vol 13, Iss 173, p 173 (2020)
Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field